We are live on ! Find out more
LPC

Loeb Partners Corp Portfolio holdings

AUM $4.86M
1-Year Est. Return 7.22%
This Fund
S&P 500
This Quarter Est. Return
+13.67%
1 Year Est. Return
+7.22%
3 Year Est. Return
+34.39%
5 Year Est. Return
+94.89%
10 Year Est. Return
AUM
$4.86M
AUM Growth
-$210M
Cap. Flow
-$220M
Cap. Flow %
-4,519.26%
Top 10 Hldgs %
46.43%
Holding
336
New
4
Increased
3
Reduced
95
Closed
179

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$32.5K
2
CSCO icon
Cisco
CSCO
+$21.9K
3
MRNA icon
Moderna
MRNA
+$14.8K
4
ARE icon
Alexandria Real Estate Equities
ARE
+$6.58K
5
NKTR icon
Nektar Therapeutics
NKTR
+$5.93K

Sector Composition

Rank Sector Weight
1 Healthcare 26.3%
2 Technology 22.52%
3 Financials 13.63%
4 Communication Services 8.7%
5 Consumer Staples 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
1
Thermo Fisher Scientific
TMO
$198B
$428K 8.8%
1,570
-250
-14% -$62.2K
MSFT icon
2
Microsoft
MSFT
$2.93T
$354K 7.28%
3,000
-36,620
-92% -$4M
BRK.A icon
3
Berkshire Hathaway Class A
BRK.A
$1.06T
$301K 6.19%
1
-31
-97% -$9.39M
AAPL icon
4
Apple
AAPL
$4.9T
$212K 4.36%
4,460
-6,000
-57% -$255K
META icon
5
Meta Platforms (Facebook)
META
$1.64T
$211K 4.34%
1,255
-8,650
-87% -$1.38M
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.06T
$201K 4.13%
1,000
-49,000
-98% -$9.89M
IBM icon
7
IBM
IBM
$200B
$187K 3.85%
1,386
-105
-7% -$13.4K
ARE icon
8
Alexandria Real Estate Equities
ARE
$8.75B
$148K 3.04%
1,030
+50
+5% +$6.58K
DHR icon
9
Danaher
DHR
$144B
$112K 2.3%
959
LLY icon
10
Eli Lilly
LLY
$1.05T
$104K 2.14%
800
-10,400
-93% -$1.26M
MRK icon
11
Merck
MRK
$315B
$104K 2.14%
1,310
-105
-7% -$7.85K
GD icon
12
General Dynamics
GD
$99.7B
$84K 1.73%
500
-100
-17% -$16.8K
PFE icon
13
Pfizer
PFE
$143B
$81K 1.67%
2,045
-6,403
-76% -$256K
WMT icon
14
Walmart Inc
WMT
$909B
$80K 1.65%
2,400
-300
-11% -$9.73K
PG icon
15
Procter & Gamble
PG
$349B
$71K 1.46%
690
-39,100
-98% -$3.81M
T icon
16
AT&T
T
$152B
$71K 1.46%
2,972
-126,273
-98% -$2.9M
JNJ icon
17
Johnson & Johnson
JNJ
$609B
$66K 1.36%
475
-29,700
-98% -$3.98M
BMY icon
18
Bristol-Myers Squibb
BMY
$124B
$62K 1.27%
1,300
-260
-17% -$13K
NKE icon
19
Nike
NKE
$64.9B
$62K 1.27%
750
-300
-29% -$24.8K
CSCO icon
20
Cisco
CSCO
$441B
$59K 1.21%
1,100
+450
+69% +$21.9K
A icon
21
Agilent Technologies
A
$37.1B
$56K 1.15%
700
-200
-22% -$15.2K
GLD icon
22
SPDR Gold Trust
GLD
$130B
$55K 1.13%
450
-27,313
-98% -$3.36M
BOX icon
23
Box
BOX
$4.22B
$54K 1.11%
2,700
-400
-13% -$8.29K
ABBV icon
24
AbbVie
ABBV
$450B
$52K 1.07%
650
-2,120
-77% -$173K
MRVL icon
25
Marvell Technology
MRVL
$169B
$49K 1.01%
2,450
-300
-11% -$5.61K

Similar funds

Loeb Partners Corp's Q1 2019 Portfolio in Review

As of Q1 2019, Loeb Partners Corp held 336 positions worth $4.86M, down 98% from $215M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Loeb Partners Corp withdrew a net $220M in Q1 2019, closing 179 positions and reducing 95 holdings. Its most notable exit was iShares S&P 500 Value ETF, an estimated $4.55M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 6.3% a quarter earlier, followed by Technology and Financials.

Against the trend, Loeb Partners Corp opened a new position in Unilever worth $36K.

  • Loeb Partners Corp's largest Q1 2019 buy was Unilever: 533 shares worth $36K.
  • Loeb Partners Corp added most to Cisco in Q1 2019, an estimated $21.9K increase.
  • Loeb Partners Corp's biggest Q1 2019 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $9.9M.
  • Loeb Partners Corp fully exited iShares S&P 500 Value ETF in Q1 2019, selling an estimated $4.55M.
  • Loeb Partners Corp's ten largest holdings make up 46% of its $4.86M portfolio in Q1 2019.
  • Loeb Partners Corp opened 4 new positions and closed 179 in Q1 2019.
  • Loeb Partners Corp's portfolio value fell 98% quarter-over-quarter to $4.86M.

Based on Loeb Partners Corp's 13F filing for Q1 2019, filed 14 May 2019.